Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-10

FDA Approved: VEMLIDY — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA granted original approval to Vemlidy (tenofovir alafenamide) from Gilead Sciences for the treatment of chronic hepatitis B virus infection. This marks the i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vemlidy (tenofovir alafenamide)

Snippet

ORIG AP for VEMLIDY (TENOFOVIR ALAFENAMIDE)